Search for: "Anda Pharmaceuticals, Inc"
Results 401 - 420
of 607
Sort by Relevance
|
Sort by Date
21 Dec 2010, 11:00 am
(“Sandoz”) requests from the Agency a written decision that Cobrek Pharmaceuticals, Inc. [read post]
19 Dec 2010, 9:26 pm
Medicis Pharmaceutical Corp. v. [read post]
17 Dec 2010, 7:47 am
(Nasdaq: MYL) today confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc. have been sued by Shionogi Pharma Inc. and CIMA LABS INC. in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. [read post]
14 Dec 2010, 7:06 pm
Keith Webber, Deputy Director of the Office of Pharmaceutical Science (and acting OGD Director) determined that the five criteria are a “valid approach . . . for purposes of ANDA approval. [read post]
12 Dec 2010, 9:47 pm
-Florida; Watson Pharma, Inc.; Anda, Inc. [read post]
24 Nov 2010, 12:37 am
General Global pharmaceutical linkage regulations: A consortium framework (IP Osgoode) Pfizer rolling out generics to grab off-patent market (GenericsWeb) Australia: Too little too late: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (No 2) and the judicial discretion to amend a patent (IP Whiteboard) Brazil: You lost your chance! [read post]
23 Nov 2010, 9:54 pm
Noonan -- The Federal Trade Commission is nothing if not persistent in trying to eliminate "reverse payment" settlements in ANDA litigation, even going so far as to "forum shop" to do so, according to a brief by appellees Unimed Pharmaceuticals LLC, Abbott Products, Inc., and Watson Pharmaceuticals, Inc. [read post]
10 Nov 2010, 6:22 am
., Inc. v. [read post]
9 Nov 2010, 3:09 pm
On March 19, 2007, Barr Laboratories, Inc. and Barr Pharmaceuticals, Inc. [read post]
4 Nov 2010, 1:24 pm
Wyeth, Inc., 85 Cal. [read post]
3 Nov 2010, 7:00 am
Walters On October 25, Amphastar Pharmaceuticals, Inc. [read post]
31 Oct 2010, 9:06 pm
Zydus Pharmaceuticals USA, Inc. v. [read post]
28 Oct 2010, 9:23 pm
In re Andrx Pharmaceuticals, Inc., Misc. [read post]
28 Oct 2010, 10:14 am
On June 28th, 2010, Sandoz Inc. replied to the Company’s correspondence. [read post]
25 Oct 2010, 10:52 am
Karst – FDA’s recent decision to grant an April 27, 2010 citizen petition submitted on behalf of Genzyme Corporation (“Genzyme”) concerning the Agency’s ability to approve Cobrek Pharmaceuticals, Inc. [read post]
19 Oct 2010, 7:31 am
The following is excerpted from an October 18, 2010 Somaxon press release published at Business Wire: Somaxon Pharmaceuticals, Inc. [read post]
12 Oct 2010, 9:59 pm
§ 2201) in the Hatch-Waxman context in Teva Pharmaceuticals USA, Inc. v. [read post]
6 Oct 2010, 11:43 pm
Sepracor Inc., concerning Dey’s ANDAs for generic versions of Sepracor’s XOPENEX (levalbuterol HCl) – the U.S. [read post]
6 Oct 2010, 4:31 pm
By Jason RantanenTeva Pharmaceuticals USA, Inc. v. [read post]
6 Oct 2010, 4:22 am
Sandoz, Inc. et al (Docket Report) [read post]
